Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

FSD Pharma Inc C.HUGE

Alternate Symbol(s):  HUGE

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.


CSE:HUGE - Post by User

Post by kishamaranason Dec 22, 2020 9:21am
79 Views
Post# 32159714

Developing Treatment

Developing Treatment
 
 
According to the Center for Disease and Control and Prevention, approximately 1% of children globally suffer from autism. In the United States only, an estimated figure is given of 1 out of almost 70 births in the country. It is marked as one of the fastest growing developmental disease increasing at a rate of approximately 119% from 2000 to the year 2014
 
Unfortunately, there is a rather large unmet medical need when it comes to ASD .But there is a compound that could potentially revolutionize the treatment of ASD- Psilocybin.
 
Then there's these other companies developing a diversified pipeline with psilocybin-based treatments claiming to target ASD.
 
With this development treatment for ASD patient would you support? Check disclaimer on profile
<< Previous
Bullboard Posts
Next >>